Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Astellas’ non-hormonal VMS therapy gets FDA approval

SHEM OIREREJune 08, 2023

Tag: VMS , Veozah , FDA , Astellas

PharmaSources Customer Service